Anaphylaxis Campaign

Supporting people at risk of severe allergies

DonateEMERGENCY INSTRUCTIONS

Explore our Website

Access our Knowledgebase
The Knowledgebase is an online resource where you can search for information about allergy.
Information for Newly Diagnosed
Around one third of the UK population (approximately 19 million people) will develop an allergy at some time in their lives.
Fundraise
From marathons to wigs, everyone can fundraise!
Events
Find out what's going on near you.
Membership
Join us as a member of the Anaphylaxis Campaign today and help us to raise the profile of severe allergy and support those who live with life threatening allergies.
AllergyWise
AllergyWise is our online e-learning website with a selection of courses for you to learn about anaphylaxis, the risks of severe allergies and how to manage them.

Topics of Interest

Managing Allergens in the Workplace

We have developed a comprehensive guide for employees and employers to help people with severe allergies at work, including an adult allergy action plan. Read more…

Support Group Events

Our Support Groups are organised by our friendly volunteers, and are the perfect chance to meet other people living with severe allergies in your local area. Read more…

Christmas

The festive period is almost upon us! We understand that the festive period can be extremely challenging for those living with a severe allergy. Read more…

 

News

EAT Study shows early exposure to allergens could stop allergies developing

6th December 2019

New findings from the London-based EAT Study have shown that giving certain allergenic foods to specific groups of babies at high risk of developing allergies, from as young as three months could reduce the likelihood of them developing an allergy to those foods. The original EAT study (2016) placed more than 1,300 babies at random […]

Read More...

MHRA issues Emerade Alert Update

28th November 2019

Thursday 28th November 2019 The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received reports of Emerade pens failing to activate. This means that in some cases, the needle is not released, and the injection of adrenaline is not delivered. This alert is an update to the previous drug alert issued […]

Read More...

EpiPen 0.3mg Auto-Injectors have Longer Shelf Life

15th November 2019

EpiPen 0.3mg auto-injector devices have now had their shelf life increased from 20 months to 24 months from the date of manufacture. Expiry dates can be found on the label on the auto-injector device and should not be used after this date. The shelf life for EpiPen 0.15mg auto-injector devices remains at 19 months from […]

Read More...

Latest NHS Digital Figures Show an Increase in Anaphylaxis Hospital Admissions in Children and Adults

15th November 2019

Latest figures reveal that hospital admissions for anaphylactic shock for all causes has risen by around 70% in the past five years, from 2013-2014 to 2018-2019, for under 18’s, as shown in the graph below. Hospital admissions for anaphylactic shock for adults has also increased from 3,092 to 3,751 in the same five-year period. See […]

Read More...